Zegocractin is under clinical development by CalciMedica and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.

* Beyond Air's LungFit PH is approved for commercial use in the United States of America to treat term and near-term neonates with hypoxic respiratory failure and in the European Union to treat ...

The specific indications for LungFit PH under CE Mark certification include: 1) the treatment of infants > 34 weeks gestation with hypoxic respiratory failure associated with clinical or ...

Rubens, known for his beloved character Pee-wee Herman, died on July 30 from acute hypoxic respiratory failure at the age of 70, after keeping his cancer diagnosis private for years. Paragon ...

Indication covers newborn infants with hypoxic respiratory failure and peri- and post-operative pulmonary hypertension to improve right ventricular function in conjunction with heart surgery A $1 ...

High-flow nasal oxygen (HFNO) is noninferior to noninvasive ventilation (NIV) for endotracheal intubation or death within ...

NHF therapy is generally preferred for hypoxemic respiratory failure and to minimize post-extubation and post-operative respiratory failure, but its range of uses is expanding particularly outside ...